Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05546385Not ApplicableTerminated

PArtial REbreathing for Migraine With Aura 1

Role: lead

NCT03472417Not ApplicableCompleted

Partial Rebreathing in the Treatment of Migraine With Aura

Role: collaborator

NCT01575665Not ApplicableCompleted

Normalizing CO2 in Chronic Hyperventilation by a Novel Breathing Mask: A Pilot Study

Role: collaborator

All 3 trials loaded